Tina Marriott Larson
Insider
First SEC filing: April 15, 2021 · Latest: April 15, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 15, 2024 | RXRX | F | 14,286 | $6.18 | $88,287 | 506,852 Direct | -2.74% | Disposed | -24.7% (price as of 2026-10-06) |
| Oct. 24, 2024 | RXRX | M 10b5-1 | 6,000 | $1.06 | $6,360 | 527,138 Direct | +1.15% | Acquired | 339.2% (price as of 2026-10-06) |
| Oct. 24, 2024 | RXRX | S 10b5-1 | 6,000 | $6.31 | $37,860 | 521,138 Direct | -1.14% | Disposed | -26.2% (price as of 2026-10-06) |
| Oct. 24, 2024 | RXRX | M 10b5-1 | 6,000 | · | · | 452,000 Direct | -1.31% | Disposed | (price as of 2026-10-06) |
| Sept. 26, 2024 | RXRX | M 10b5-1 | 6,000 | $1.06 | $6,360 | 527,138 Direct | +1.15% | Acquired | 339.2% (price as of 2026-10-06) |
| Sept. 26, 2024 | RXRX | S 10b5-1 | 6,000 | $7.00 | $42,000 | 521,138 Direct | -1.14% | Disposed | -33.5% (price as of 2026-10-06) |
| Sept. 26, 2024 | RXRX | M 10b5-1 | 0 | · | · | 458,000 Direct | 0.00% | Disposed | (price as of 2026-10-06) |
| Aug. 29, 2024 | RXRX | M 10b5-1 | 6,000 | $1.06 | $6,360 | 527,138 Direct | +1.15% | Acquired | 339.2% (price as of 2026-10-06) |
| Aug. 29, 2024 | RXRX | S 10b5-1 | 6,000 | $7.56 | $45,360 | 521,138 Direct | -1.14% | Disposed | -38.4% (price as of 2026-10-06) |
| Aug. 29, 2024 | RXRX | M 10b5-1 | 6,000 | · | · | 464,000 Direct | -1.28% | Disposed | (price as of 2026-10-06) |
| Aug. 15, 2024 | RXRX | F | 14,319 | $6.69 | $95,794 | 521,138 Direct | -2.67% | Disposed | -30.4% (price as of 2026-10-06) |
| July 25, 2024 | RXRX | M 10b5-1 | 6,000 | $1.06 | $6,360 | 541,457 Direct | +1.12% | Acquired | 339.2% (price as of 2026-10-06) |
| July 25, 2024 | RXRX | S 10b5-1 | 6,000 | $8.13 | $48,780 | 535,457 Direct | -1.11% | Disposed | -42.7% (price as of 2026-10-06) |
| July 25, 2024 | RXRX | M 10b5-1 | 6,000 | · | · | 470,000 Direct | -1.26% | Disposed | (price as of 2026-10-06) |
| June 27, 2024 | RXRX | M 10b5-1 | 6,000 | $1.06 | $6,360 | 541,457 Direct | +1.12% | Acquired | 339.2% (price as of 2026-10-06) |
| June 27, 2024 | RXRX | S 10b5-1 | 6,000 | $7.22 | $43,320 | 535,457 Direct | -1.11% | Disposed | -35.5% (price as of 2026-10-06) |
| June 27, 2024 | RXRX | M 10b5-1 | 6,000 | · | · | 476,000 Direct | -1.24% | Disposed | (price as of 2026-10-06) |
| May 30, 2024 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 538,457 Direct | +0.56% | Acquired | 339.2% (price as of 2026-10-06) |
| May 30, 2024 | RXRX | S 10b5-1 | 3,000 | $8.78 | $26,340 | 535,457 Direct | -0.56% | Disposed | -47.0% (price as of 2026-10-06) |
| May 30, 2024 | RXRX | M 10b5-1 | 0 | · | · | 482,000 Direct | 0.00% | Disposed | (price as of 2026-10-06) |
| May 15, 2024 | RXRX | F | 9,998 | $10.01 | $100,080 | 533,233 Direct | -1.84% | Disposed | -53.5% (price as of 2026-10-06) |
| April 25, 2024 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 546,231 Direct | +0.55% | Acquired | 339.2% (price as of 2026-10-06) |
| April 25, 2024 | RXRX | S 10b5-1 | 3,000 | $7.67 | $23,010 | 543,231 Direct | -0.55% | Disposed | -39.3% (price as of 2026-10-06) |
| April 25, 2024 | RXRX | M 10b5-1 | 3,000 | · | · | 485,000 Direct | -0.61% | Disposed | (price as of 2026-10-06) |
| March 21, 2024 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 647,982 Direct | +1.25% | Acquired | 339.2% (price as of 2026-10-06) |
| March 21, 2024 | RXRX | S 10b5-1 | 7,390 | $10.70 | $79,073 | 640,592 Direct | -1.14% | Disposed | -56.5% (price as of 2026-10-06) |
| March 21, 2024 | RXRX | S 10b5-1 | 610 | $11.34 | $6,917 | 639,982 Direct | -0.10% | Disposed | -59.0% (price as of 2026-10-06) |
| March 21, 2024 | RXRX | M 10b5-1 | 8,000 | · | · | 488,000 Direct | -1.61% | Disposed | (price as of 2026-10-06) |
| Feb. 22, 2024 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 647,982 Direct | +1.25% | Acquired | 339.2% (price as of 2026-10-06) |
| Feb. 22, 2024 | RXRX | S 10b5-1 | 8,000 | $14.90 | $119,200 | 639,982 Direct | -1.23% | Disposed | -68.8% (price as of 2026-10-06) |
| Feb. 22, 2024 | RXRX | M | 8,000 | · | · | 496,000 Direct | -1.59% | Disposed | (price as of 2026-10-06) |
| Feb. 15, 2024 | RXRX | F | 5,379 | $12.43 | $66,861 | 639,982 Direct | -0.83% | Disposed | -62.6% (price as of 2026-10-06) |
| Feb. 9, 2024 | RXRX | A | 447,917 | · | · | 447,917 Direct | · | Acquired | (price as of 2026-10-06) |
| Feb. 9, 2024 | RXRX | F | 2,800 | $10.09 | $28,252 | 645,361 Direct | -0.43% | Disposed | -53.9% (price as of 2026-10-06) |
| Feb. 9, 2024 | RXRX | A | 223,958 | · | · | 648,161 Direct | +52.80% | Acquired | (price as of 2026-10-06) |
| Feb. 9, 2024 | RXRX | A | 9,655 | · | · | 424,203 Direct | +2.33% | Acquired | (price as of 2026-10-06) |
| Jan. 25, 2024 | RXRX | M 10b5-1 | 8,000 | · | · | 504,000 Direct | -1.56% | Disposed | (price as of 2026-10-06) |
| Jan. 25, 2024 | RXRX | S 10b5-1 | 8,000 | $10.35 | $82,800 | 414,548 Direct | -1.89% | Disposed | -55.0% (price as of 2026-10-06) |
| Jan. 25, 2024 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 422,584 Direct | +1.93% | Acquired | 339.2% (price as of 2026-10-06) |
| Dec. 28, 2023 | RXRX | M 10b5-1 | 8,000 | · | · | 512,000 Direct | -1.54% | Disposed | (price as of 2026-10-06) |
| Dec. 28, 2023 | RXRX | S 10b5-1 | 8,000 | $10.58 | $84,640 | 414,548 Direct | -1.89% | Disposed | -56.0% (price as of 2026-10-06) |
| Dec. 28, 2023 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 422,548 Direct | +1.93% | Acquired | 339.2% (price as of 2026-10-06) |
| Nov. 16, 2023 | RXRX | M 10b5-1 | 3,000 | · | · | 520,000 Direct | -0.57% | Disposed | (price as of 2026-10-06) |
| Nov. 16, 2023 | RXRX | S 10b5-1 | 3,000 | $6.76 | $20,280 | 413,404 Direct | -0.72% | Disposed | -31.1% (price as of 2026-10-06) |
| Nov. 16, 2023 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 416,404 Direct | +0.73% | Acquired | 339.2% (price as of 2026-10-06) |
| Nov. 15, 2023 | RXRX | F | 5,378 | $7.18 | $38,614 | 413,404 Direct | -1.28% | Disposed | -35.2% (price as of 2026-10-06) |
| Oct. 26, 2023 | RXRX | M 10b5-1 | 3,000 | · | · | 523,000 Direct | -0.57% | Disposed | (price as of 2026-10-06) |
| Oct. 26, 2023 | RXRX | S 10b5-1 | 3,000 | $5.63 | $16,890 | 418,782 Direct | -0.71% | Disposed | -17.3% (price as of 2026-10-06) |
| Oct. 26, 2023 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 421,782 Direct | +0.72% | Acquired | 339.2% (price as of 2026-10-06) |
| Sept. 28, 2023 | RXRX | M 10b5-1 | 3,000 | · | · | 526,000 Direct | -0.57% | Disposed | (price as of 2026-10-06) |
| Sept. 28, 2023 | RXRX | S 10b5-1 | 3,000 | $7.72 | $23,160 | 418,782 Direct | -0.71% | Disposed | -39.7% (price as of 2026-10-06) |
| Sept. 28, 2023 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 421,782 Direct | +0.72% | Acquired | 339.2% (price as of 2026-10-06) |
| Aug. 24, 2023 | RXRX | M 10b5-1 | 3,000 | · | · | 529,000 Direct | -0.56% | Disposed | (price as of 2026-10-06) |
| Aug. 24, 2023 | RXRX | S 10b5-1 | 63 | $9.45 | $595 | 418,782 Direct | -0.02% | Disposed | -50.7% (price as of 2026-10-06) |
| Aug. 24, 2023 | RXRX | S 10b5-1 | 2,937 | $8.64 | $25,376 | 418,845 Direct | -0.70% | Disposed | -46.1% (price as of 2026-10-06) |
| Aug. 24, 2023 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 421,782 Direct | +0.72% | Acquired | 339.2% (price as of 2026-10-06) |
| Aug. 15, 2023 | RXRX | F | 5,378 | $9.18 | $49,370 | 418,782 Direct | -1.27% | Disposed | -49.3% (price as of 2026-10-06) |
| July 29, 2023 | RXRX | M 10b5-1 | 8,000 | · | · | 532,000 Direct | -1.48% | Disposed | (price as of 2026-10-06) |
| July 27, 2023 | RXRX | S 10b5-1 | 4,373 | $14.05 | $61,441 | 424,160 Direct | -1.02% | Disposed | -66.9% (price as of 2026-10-06) |
| July 27, 2023 | RXRX | S 10b5-1 | 3,627 | $13.12 | $47,586 | 428,533 Direct | -0.84% | Disposed | -64.5% (price as of 2026-10-06) |
| July 27, 2023 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 432,160 Direct | +1.89% | Acquired | 339.2% (price as of 2026-10-06) |
| June 29, 2023 | RXRX | M 10b5-1 | 3,000 | · | · | 540,000 Direct | -0.55% | Disposed | (price as of 2026-10-06) |
| June 29, 2023 | RXRX | S 10b5-1 | 3,000 | $7.49 | $22,470 | 424,160 Direct | -0.70% | Disposed | -37.9% (price as of 2026-10-06) |
| June 29, 2023 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 427,160 Direct | +0.71% | Acquired | 339.2% (price as of 2026-10-06) |
| May 31, 2023 | RXRX | M 10b5-1 | 3,000 | · | · | 543,000 Direct | -0.55% | Disposed | (price as of 2026-10-06) |
| May 31, 2023 | RXRX | S 10b5-1 | 3,000 | $8.63 | $25,890 | 424,160 Direct | -0.70% | Disposed | -46.1% (price as of 2026-10-06) |
| May 31, 2023 | RXRX | M 10b5-1 | 3,000 | $1.06 | $3,180 | 427,160 Direct | +0.71% | Acquired | 339.2% (price as of 2026-10-06) |
| May 15, 2023 | RXRX | F | 5,415 | $5.60 | $30,324 | 422,429 Direct | -1.27% | Disposed | -16.9% (price as of 2026-10-06) |
| Feb. 23, 2023 | RXRX | M 10b5-1 | 8,000 | · | · | 546,000 Direct | -1.44% | Disposed | (price as of 2026-10-06) |
| Feb. 23, 2023 | RXRX | S 10b5-1 | 8,000 | $7.82 | $62,560 | 427,844 Direct | -1.84% | Disposed | -40.5% (price as of 2026-10-06) |
| Feb. 23, 2023 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 435,844 Direct | +1.87% | Acquired | 339.2% (price as of 2026-10-06) |
| Feb. 15, 2023 | RXRX | F | 1,603 | $8.44 | $13,529 | 427,844 Direct | -0.37% | Disposed | -44.8% (price as of 2026-10-06) |
| Feb. 1, 2023 | RXRX | A | 434,122 | · | · | 434,122 Direct | · | Acquired | (price as of 2026-10-06) |
| Feb. 1, 2023 | RXRX | F | 3,093 | $8.55 | $26,445 | 429,447 Direct | -0.72% | Disposed | -45.6% (price as of 2026-10-06) |
| Feb. 1, 2023 | RXRX | A | 9,732 | · | · | 432,540 Direct | +2.30% | Acquired | (price as of 2026-10-06) |
| Feb. 1, 2023 | RXRX | A | 217,061 | · | · | 422,808 Direct | +105.50% | Acquired | (price as of 2026-10-06) |
| Jan. 26, 2023 | RXRX | M 10b5-1 | 8,000 | · | · | 554,000 Direct | -1.42% | Disposed | (price as of 2026-10-06) |
| Jan. 26, 2023 | RXRX | S 10b5-1 | 8,000 | $8.07 | $64,560 | 203,654 Direct | -3.78% | Disposed | -42.3% (price as of 2026-10-06) |
| Jan. 26, 2023 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 211,654 Direct | +3.93% | Acquired | 339.2% (price as of 2026-10-06) |
| Dec. 29, 2022 | RXRX | M 10b5-1 | 8,000 | · | · | 562,000 Direct | -1.40% | Disposed | (price as of 2026-10-06) |
| Dec. 29, 2022 | RXRX | S 10b5-1 | 8,000 | $7.70 | $61,600 | 203,654 Direct | -3.78% | Disposed | -39.5% (price as of 2026-10-06) |
| Dec. 29, 2022 | RXRX | M 10b5-1 | 8,000 | $1.06 | $8,480 | 211,654 Direct | +3.93% | Acquired | 339.2% (price as of 2026-10-06) |
| Nov. 17, 2022 | RXRX | M 10b5-1 | 16,000 | · | · | 570,000 Direct | -2.73% | Disposed | (price as of 2026-10-06) |
| Nov. 17, 2022 | RXRX | S 10b5-1 | 16,000 | $10.96 | $175,360 | 203,654 Direct | -7.28% | Disposed | -57.5% (price as of 2026-10-06) |
| Nov. 17, 2022 | RXRX | M 10b5-1 | 16,000 | $1.06 | $16,960 | 219,654 Direct | +7.86% | Acquired | 339.2% (price as of 2026-10-06) |
| Nov. 15, 2022 | RXRX | F | 1,453 | $11.86 | $17,233 | 203,654 Direct | -0.71% | Disposed | -60.8% (price as of 2026-10-06) |
| Oct. 27, 2022 | RXRX | M 10b5-1 | 16,000 | · | · | 586,000 Direct | -2.66% | Disposed | (price as of 2026-10-06) |
| Oct. 27, 2022 | RXRX | S 10b5-1 | 16,000 | $10.72 | $171,520 | 205,107 Direct | -7.24% | Disposed | -56.6% (price as of 2026-10-06) |
| Oct. 27, 2022 | RXRX | M 10b5-1 | 16,000 | $1.06 | $16,960 | 221,107 Direct | +7.80% | Acquired | 339.2% (price as of 2026-10-06) |
| Sept. 29, 2022 | RXRX | M 10b5-1 | 16,000 | · | · | 602,000 Direct | -2.59% | Disposed | (price as of 2026-10-06) |
| Sept. 29, 2022 | RXRX | S 10b5-1 | 64 | $11.53 | $738 | 205,107 Direct | -0.03% | Disposed | -59.6% (price as of 2026-10-06) |
| Sept. 29, 2022 | RXRX | S 10b5-1 | 15,936 | $10.86 | $173,065 | 205,171 Direct | -7.21% | Disposed | -57.1% (price as of 2026-10-06) |
| Sept. 29, 2022 | RXRX | M 10b5-1 | 16,000 | $1.06 | $16,960 | 221,107 Direct | +7.80% | Acquired | 339.2% (price as of 2026-10-06) |
| Aug. 16, 2022 | RXRX | M 10b5-1 | 16,000 | · | · | 618,000 Direct | -2.52% | Disposed | (price as of 2026-10-06) |
| Aug. 16, 2022 | RXRX | S 10b5-1 | 16,000 | $12.60 | $201,600 | 295,107 Direct | -5.14% | Disposed | -63.1% (price as of 2026-10-06) |
| Aug. 16, 2022 | RXRX | M 10b5-1 | 16,000 | $1.06 | $16,960 | 221,107 Direct | +7.80% | Acquired | 339.2% (price as of 2026-10-06) |
| Aug. 15, 2022 | RXRX | F | 1,453 | $12.96 | $18,831 | 205,107 Direct | -0.70% | Disposed | -64.1% (price as of 2026-10-06) |
| May 16, 2022 | RXRX | F 10b5-1 | 1,458 | $5.67 | $8,267 | 206,560 Direct | -0.70% | Disposed | -17.9% (price as of 2026-10-06) |
| March 4, 2022 | RXRX | M | 58,500 | · | · | 634,000 Direct | +10.17% | Acquired | (price as of 2026-10-06) |
| March 4, 2022 | RXRX | M | 58,500 | $1.06 | $62,010 | 208,018 Direct | +39.13% | Acquired | 339.2% (price as of 2026-10-06) |
Showing latest 100 of 120 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 24, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 6,000 | Disposed |
| Sept. 26, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 0 | Disposed |
| Aug. 29, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 6,000 | Disposed |
| July 25, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 6,000 | Disposed |
| June 27, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 6,000 | Disposed |
| May 30, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 0 | Disposed |
| April 25, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 3,000 | Disposed |
| March 21, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| Feb. 22, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| Feb. 9, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $10.09 | Feb. 9, 2034 | 447,917 | Acquired |
| Jan. 25, 2024 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| Dec. 28, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| Nov. 16, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 3,000 | Disposed |
| Oct. 26, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 3,000 | Disposed |
| Sept. 28, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 3,000 | Disposed |
| Aug. 24, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 3,000 | Disposed |
| July 29, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| June 29, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 3,000 | Disposed |
| May 31, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 3,000 | Disposed |
| Feb. 23, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| Feb. 1, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $8.55 | Feb. 1, 2033 | 434,122 | Acquired |
| Jan. 26, 2023 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| Dec. 29, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 8,000 | Disposed |
| Nov. 17, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 16,000 | Disposed |
| Oct. 27, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 16,000 | Disposed |
| Sept. 29, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 16,000 | Disposed |
| Aug. 16, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 16,000 | Disposed |
| March 4, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 58,500 | Acquired |
| Feb. 18, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 16,000 | Acquired |
| Feb. 14, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $1.06 | July 22, 2028 | 4,000 | Acquired |
| Feb. 4, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $11.40 | Feb. 4, 2032 | 4,784 | Acquired |
| Feb. 4, 2022 | RXRX | Stock Option (Right to Buy) | Class A Common Stock | $11.40 | Feb. 4, 2032 | 159,226 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Class A Common Stock [F1] | $2.47 | Dec. 30, 2030 | 150,000 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Class A Common Stock [F1] | $1.06 | July 22, 2028 | 712,500 | Acquired |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Common Stock [F1] | $2.47 | Dec. 30, 2030 | 150,000 | Disposed |
| April 20, 2021 | RXRX | Stock Option (Right to Buy) | Common Stock [F1] | $1.06 | July 22, 2028 | 712,500 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $408,192 | $13,000 | · | $226,866 | $30,070 | · | $12,700 | $690,828 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.